Log In
BCIQ
Print this Print this
 

memantine extended release (ER)

  Manage Alerts
Collapse Summary General Information
Company Merz GmbH & Co. KGaA
DescriptionNMDA receptor antagonist
Molecular Target NMDA receptor
Mechanism of ActionNMDA receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat moderate to severe Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today